Arthur Elliot Hirshorn alias Dr. 85-Marker Mirage

Arthur Elliot Hirshorn is not licensed or approved by South Carolina Board of Chiropractic Examiners to diagnose, treat, or cure There are 24 distinct patterns of thyroid dysfunction..

There are 24 distinct patterns of thyroid dysfunction.

Supports

None of the indexed peer-reviewed papers describe or endorse a classification system with exactly 24 distinct patterns of thyroid dysfunction. ^[1][2][4] Standard clinical and guideline-based frameworks instead describe a limited set of biochemical states (overt hypothyroidism, overt hyperthyroidism, subclinical hypothyroidism, subclinical hyperthyroidism, central/secondary/tertiary hypothyroidism) and various etiologic categories (autoimmune thyroiditis, postpartum thyroiditis, subacute thyroiditis, drug-induced, congenital, nodular disease, cancer). ^[3] Major reviews and meta-analyses examining thyroid dysfunction as a risk factor or comorbidity (e. g. , in juvenile idiopathic arthritis, ejaculatory dysfunction, vertebral fracture, or pregnancy) consistently use these conventional categories and do not reference 24 distinct patterns.

Contradicts

High-quality sources on thyroid dysfunction use relatively simple, widely agreed classifications based on TSH and thyroid hormone levels, such as overt vs subclinical hypothyroidism and hyperthyroidism, rather than a large fixed number of patterns. ^[3][4] A commonly cited biochemical classification table describes a handful of thyroid dysfunction states (e. ^[2] g. , overt hyperthyroidism, overt hypothyroidism, subclinical hyperthyroidism, subclinical hypothyroidism) but does not approach 24 categories. Major guidelines (e. g. , from the American Thyroid Association, European Thyroid Association, NICE, USPSTF) focus on these few clinical/biochemical entities and etiologic causes; none propose or use a schema of 24 distinct thyroid dysfunction patterns. The existence of popular or functional-medicine schemas with 6 or more "patterns" of hypothyroidism reflects informal clinical heuristics rather than peer-reviewed, guideline-backed taxonomies and does not extend to 24 distinct, validated patterns. Overall, the claim of 24 distinct patterns lacks support in mainstream peer-reviewed literature and formal guidelines.

Mainstream view

The mainstream medical view is that thyroid dysfunction is best classified by a small number of well-defined biochemical and clinical states: overt hypothyroidism, overt hyperthyroidism, subclinical hypothyroidism, subclinical hyperthyroidism, and central (secondary/tertiary) hypothyroidism, plus euthyroid status. ^[3][4] These states are further subdivided by etiology (e. g. , autoimmune Hashimoto thyroiditis, Graves disease, postpartum and subacute thyroiditis, drug-induced dysfunction, congenital hypothyroidism, nodular disease, thyroid cancer) and by severity (such as degrees of TSH elevation in subclinical hypothyroidism), but not into a fixed large number like 24. ^[2] Major guidelines and reviews consistently use these limited, standardized categories for diagnosis, screening, and management and do not recognize a 24-pattern classification as an evidence-based or clinically accepted framework. Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

▶ 0:39In their own wordsWatch at 0:39

“At New Life Health, we understand that there are 24 different patterns of thyroid dysfunction.”

Rule: S.C. Code § 40-9-10(b); S.C. Code Regs. Chapter 25, § 25-1(1)-(2)

Arthur Elliot Hirshorn is not licensed or approved by South Carolina Board of Chiropractic Examiners to diagnose, treat, or cure Over 80% of thyroid symptom cases are autoimmune (Hashimoto's) and the immune system is attacking the thyroid..

Over 80% of thyroid symptom cases are autoimmune (Hashimoto's) and the immune system is attacking the thyroid.

Supports

High-quality reviews and major references consistently identify Hashimoto thyroiditis as the most common autoimmune thyroid disease and a leading cause of hypothyroidism in iodine-sufficient settings. ^{[9][10][11][12]} The claim’s first half is directionally supported insofar as autoimmune thyroiditis is a major cause of thyroid dysfunction, and Hashimoto’s pathology involves immune-mediated thyroid destruction. Some clinical reviews also note that thyroid symptoms can be nonspecific and that many patients with Hashimoto’s eventually develop hypothyroid symptoms, which are the symptom cluster people often attribute to “thyroid problems”. ^[6]

Contradicts

The specific statement that over 80% of thyroid symptom cases are autoimmune is not established by the cited evidence and is too broad because “thyroid symptoms” is not the same as thyroid disease, and symptoms such as fatigue, weight change, constipation, anxiety, or palpitations have many non-thyroid causes. ^[9][10] The literature found here supports Hashimoto’s as the most common cause of spontaneous hypothyroidism in iodine-sufficient regions, but not that it accounts for more than 80% of all thyroid symptom presentations. Population data show Hashimoto’s prevalence is far below 80% in adults overall, with meta-analytic estimates around 7. ^[12] 5% globally, which makes an 80% share of all thyroid symptom cases implausible without a much narrower definition of the denominator. The phrase that “the immune system is attacking the thyroid” is accurate for Hashimoto’s itself, but it does not apply to all thyroid symptoms, since many symptomatic patients have non-autoimmune thyroid disorders or non-thyroid explanations for their symptoms. ^[11]

Mainstream view

Mainstream endocrinology recognizes Hashimoto thyroiditis as an autoimmune disease and the leading cause of hypothyroidism in iodine-sufficient populations, but it does not support the claim that more than 80% of thyroid symptom cases are autoimmune. ^{[9][10][11][12]} A more accurate statement is that a large share of diagnosed hypothyroidism in iodine-sufficient regions is autoimmune, while many thyroid-like symptoms are nonspecific and require laboratory confirmation before attributing them to thyroid autoimmunity.

▶ 1:01In their own wordsWatch at 1:01

“for over 80% of people struggling with thyroid-related symptoms, there's often an autoimmune component, meaning your thyroid may not actually be the root problem. Your immune system may be attacking your thyroid”

Rule: S.C. Code § 40-9-10(b)

Arthur Elliot Hirshorn is not licensed or approved by South Carolina Board of Chiropractic Examiners to diagnose, treat, or cure We use a proprietary 85-marker comprehensive panel to diagnose root causes of thyroid dysfunction..

We use a proprietary 85-marker comprehensive panel to diagnose root causes of thyroid dysfunction.

Supports

The indexed papers provided by the user are not about laboratory diagnosis of thyroid dysfunction or multi-marker thyroid panels, so they do not directly support the claim about using an 85‑marker panel to diagnose root causes of thyroid dysfunction. ^[20] High‑quality guidelines and reviews from major thyroid societies and public health bodies consistently describe diagnostic evaluation of thyroid dysfunction using a relatively small set of validated laboratory markers (TSH, free T4, sometimes free T3, and selected autoantibodies), plus clinical assessment and imaging only when indicated. ^{[14][15][17][21]} These sources describe modern immunoassay technology and standardization efforts but do not endorse very large proprietary marker panels as necessary or evidence‑based for diagnosis of thyroid dysfunction. ^[16][18] There is limited observational and expert‑opinion level discussion in some functional and integrative medicine sources of “expanded thyroid panels” (for example including reverse T3, additional antibodies, or micronutrients), but these are not supported by randomized controlled trials or large validation studies demonstrating superior diagnostic accuracy or improved outcomes over standard guideline‑based testing. Overall, there is no high‑quality evidence (systematic reviews, RCTs, or major guidelines) specifically supporting the need for or clinical superiority of an 85‑marker proprietary panel to diagnose root causes of thyroid dysfunction. ^[22]

Contradicts

The three index papers listed are unrelated to thyroid laboratory diagnosis and do not provide any evidence that large multi‑marker panels improve diagnosis of thyroid dysfunction, which indirectly underscores that the claim is not grounded in these references. ^[21] Authoritative guidelines and evidence reviews from organizations such as the American Thyroid Association, European Thyroid Association, USPSTF, and national testing guidelines consistently state that serum TSH is the primary screening and diagnostic test for most thyroid dysfunction, with follow‑up free T4 (and occasionally free T3) and targeted antibody testing when indicated. ^{[14][15][16][17][18][20][22]} These documents emphasize judicious, stepwise use of a small number of well‑validated tests rather than broad, indiscriminate panels. They do not recommend large proprietary panels with dozens of markers for diagnosing thyroid dysfunction or its “root causes,” nor do they present outcome data showing that such panels improve diagnosis, management, or patient‑important outcomes. Public and academic reviews on thyroid function testing also caution against over‑testing and highlight that adding many additional markers can increase costs, false positives, and diagnostic confusion without proven benefit. Taken together, the best available evidence contradicts the implication that an 85‑marker proprietary panel is an evidence‑based standard or necessary tool to diagnose the root causes of thyroid dysfunction.

Mainstream view

Mainstream endocrinology and internal medicine view thyroid dysfunction as best evaluated using a combination of history, physical examination, and a focused set of laboratory tests: usually TSH as the primary test, followed by free T4 and selected additional tests (free T3, thyroid autoantibodies, and occasionally imaging or specialized tests) based on clinical context. ^[16][17][21] Major guidelines and high‑quality reviews do not endorse very large proprietary multi‑marker panels (on the order of 85 markers) for diagnosing thyroid dysfunction or its root causes, and there is no established evidence base showing that such panels are superior to standard guideline‑directed testing. ^{[14][15][18][20][22]} The mainstream position is that broad, expensive panels without demonstrated incremental diagnostic value or outcome benefit are not recommended and should generally be avoided outside of research settings. Standardized, limited thyroid function testing remains the accepted evidence‑based approach. Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

▶ 2:54In their own wordsWatch at 2:54

“We start with a comprehensive panel of over 85 markers, including 10 thyroid-specific markers”

Rule: S.C. Code Regs. Chapter 25, § 25-1(2)(a)

Arthur Elliot Hirshorn is not licensed or approved by South Carolina Board of Chiropractic Examiners to diagnose, treat, or cure We provide a personalized root-cause plan to reverse thyroid symptoms, rejecting standard 'cookie cutter' medication protocols..

We provide a personalized root-cause plan to reverse thyroid symptoms, rejecting standard 'cookie cutter' medication protocols.

Supports

Mainstream thyroid guidelines endorse some degree of individualization of therapy (e.g., adjusting levothyroxine dose based on body weight, age, comorbidities, pregnancy, and patient-reported symptoms), and emphasize that recommendations are meant to inform but not replace individualized clinical decision-making. This means a personalized plan to manage thyroid symptoms is consistent with guideline-based care when it is anchored in appropriate diagnosis and pharmacologic treatment rather than formulaic dosing alone.^[17][21] Emerging work in precision medicine for autoimmune thyroiditis and hypothyroidism suggests that more personalized approaches (including consideration of factors like malabsorption, comorbidities, persistent symptoms, and possibly surgery in selected cases) can improve quality of life in some patients, supporting the idea that root-cause oriented assessment (e.g., looking for concomitant deficiencies, autoimmune activity, or structural thyroid disease) may be clinically useful in carefully selected cases.^[6] RCTs and integrative reviews in Hashimoto’s and autoimmune thyroid disease indicate that correcting vitamin D deficiency and other nutrient deficiencies, and using nutrient-dense diets, can modestly improve inflammatory markers and thyroid autoantibodies, which partially supports including lifestyle and nutritional factors in a personalized symptom-management plan, though not as a full replacement for standard medication when hypothyroidism is present.^[13][22]

Contradicts

Major hypothyroidism guidelines conclude that levothyroxine monotherapy remains the standard of care for treating hypothyroidism and explicitly advise against abandoning evidence-based thyroid hormone replacement in favor of alternative or unvalidated approaches.^[17][21] These guidelines also recommend against thyroid hormone treatment for patients with normal thyroid function who have nonspecific symptoms, directly contradicting marketing claims that thyroid symptoms can be broadly reversed by non-standard protocols without clear biochemical hypothyroidism.^[12][17] Precision and personalized medicine reviews for autoimmune thyroiditis and hypothyroidism stress that, despite interest in individualized strategies, high-quality evidence is still limited, and new personalized or root-cause-focused treatments require larger trials before being considered proven; they do not support claims that thyroid symptoms are routinely “reversed” by such approaches.^[6] The available RCTs and integrative dietary evidence show only modest improvements in markers and symptoms, and authoritative reviews state that no specific diet or lifestyle intervention is currently recommended as a stand-alone treatment to reverse autoimmune thyroid disease or hypothyroidism, indicating that the evidence base is too weak to justify strong reversal claims.^[22]

Mainstream view

The mainstream medical position is that thyroid disorders should be diagnosed using established criteria (TSH, free T4, and in appropriate cases thyroid antibodies and imaging) and treated primarily with guideline-directed therapy, most commonly levothyroxine for hypothyroidism, with doses individualized to clinical context and monitored over time.^[17][21] Personalized elements such as adjusting dosing for body weight, age, pregnancy, comorbidities, and symptom response, and addressing correctable factors like vitamin deficiencies or coexisting conditions, are encouraged, but they are adjuncts to—not replacements for—standard pharmacologic treatment.^[6][13][17] Current high-quality evidence does not support routine rejection of guideline-based “cookie cutter” medication protocols in favor of influencer-style root-cause programs, nor does it show that such programs reliably reverse thyroid disease or its symptoms; instead, mainstream experts view non-standard protocols as experimental or complementary, appropriate only when integrated with standard care and evaluated critically on a case-by-case basis.^[6][17][22] Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

▶ 2:17In their own wordsWatch at 2:17

“my expert team uses the same root cause system we've built over the last 13 plus years to help patients uncover what standard thyroid evaluations often miss.”

Rule: S.C. Code § 40-9-10(b); S.C. Code Regs. Chapter 25, § 25-1(1)

Arthur Elliot Hirshorn is not licensed or approved by South Carolina Board of Chiropractic Examiners to diagnose, treat, or cure Thyroid consultation service.

Thyroid consultation service

Supports

The influencer’s claim is extremely general (“Thyroid consultation service”) and does not specify any particular benefit, intervention, or outcome, so it is best interpreted as the claim that offering thyroid-focused consultations (including via telemedicine) is an appropriate and legitimate way to manage thyroid disease. ^[29] None of the indexed papers directly evaluate “thyroid consultation services” as an intervention or outcome, and only one cluster of indexed items relates to thyroid disease at all: the decision letters and review regarding the systematic review and meta-analysis on the association between Ménière’s disease and thyroid disease. These support the existence of peer‑reviewed research on thyroid disease and its associations with other conditions but do not address the effectiveness or appropriateness of consultation services. Beyond the index list, major guidelines (e. g. , American Thyroid Association, NICE, European Thyroid Association) and policy statements from endocrine societies universally assume that structured clinical assessment and follow‑up by appropriately trained clinicians is the standard way to diagnose and manage hypothyroidism, hyperthyroidism, thyroid nodules, and thyroid cancer, which inherently supports the concept that thyroid consultation by knowledgeable clinicians is appropriate care. ^[32] Telehealth and virtual thyroid consultations are also increasingly used and are supported as feasible, acceptable, and often safe when following evidence‑based guidelines and when physical examination or procedures can be arranged in person as needed. Observational and survey data (e. g. , on telemedicine for hyperthyroidism and at‑home testing plus teleconsultation for thyroid dysfunction) show high patient satisfaction and reasonable clinical handling of thyroid disorders via consultation, further indirectly supporting the claim that such services are a valid mode of care rather than a fringe practice. ^[30][31]

Contradicts

None of the indexed thyroid‑related decision letters or reviews suggest that thyroid consultation services are inappropriate or ineffective; their focus is on the association between Ménière’s disease and thyroid disease rather than care delivery. ^[29][30][31] There is, however, a lack of high‑quality randomized controlled trials or definitive comparative effectiveness studies specifically assessing “thyroid consultation services” (influencer‑style or otherwise) versus usual endocrine care, so strong claims about superior outcomes, cure rates, or unique benefits of a branded thyroid consultation service are not supported by the index set or mainstream literature. If the influencer’s underlying claim implies that their thyroid consultation service is uniquely effective, superior to standard endocrine or primary care, or based on novel methods that depart from guideline‑based practice, such assertions would be weakly supported at best and likely contradicted by the absence of evidence demonstrating superiority or improved hard outcomes (symptom control, quality of life, cardiovascular endpoints, etc. ). Existing policy statements on telehealth in endocrinology emphasize that there is currently insufficient evidence to declare telehealth (including thyroid teleconsultations) definitively better or worse than traditional care for specific endocrine diagnoses, which would contradict any strong claims of proven superiority. ^[32]

Mainstream view

Mainstream medical and endocrine practice holds that structured clinical consultation with an appropriately trained clinician (endocrinologist, internist, or suitably experienced primary care provider) is the standard, necessary approach for diagnosing and managing thyroid disease. ^{[29][30][31][32]} This includes taking a detailed history, reviewing symptoms, ordering and interpreting thyroid function tests (TSH, free T4, and where appropriate free T3), arranging imaging or biopsy for nodular disease, and titrating treatments such as levothyroxine or antithyroid drugs according to guideline‑based targets. Evidence‑based guidelines from major societies (e. g. , American Thyroid Association, NICE, European Thyroid Association) uniformly embed consultation and follow‑up visits as central to care, both in person and increasingly via telehealth, provided physical exams and procedures can be arranged when indicated. Telemedicine and virtual consultations are considered acceptable and often advantageous for many thyroid patients when they improve access, reduce travel burden, and maintain guideline‑concordant diagnostic testing and monitoring, but they are not yet proven to yield superior clinical outcomes compared with conventional visits. The mainstream view therefore fully supports the concept of thyroid consultation as appropriate care, while remaining neutral about specific branded services and cautious about unsupported claims of unique benefit.

▶ 3:36In their own wordsWatch at 3:36

“schedule your thyroid consultation with our expert team”

Rule: S.C. Code § 40-9-10(b)